Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Monday, September 1, 2014. To access the conference call, follow these instructions:
Dial: (877) 881.2183 (U.S.); (970) 315.0453 (international)
Passcode: 73168608 (Nektar Therapeutics is the host)In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics (NASDAQ: NKTR) is a biopharmaceutical company developing novel therapeutics based on its advanced polymer conjugate technology platform. Nektar has a robust R&D pipeline of potentially high-value therapeutics in pain, oncology and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Movantik™ (naloxegol), an investigational drug candidate, which has been filed for regulatory approvals in the U.S., Europe and Canada as a once- daily, oral tablet for the treatment of opioid-induced constipation. This agreement also includes Movantik fixed dose combination products (formerly NKTR-119), an earlier stage development program that is a co-formulation of Movantik and an opioid. NKTR-181, a novel mu-opioid analgesic molecule for chronic pain conditions, has completed Phase 2 development. NKTR-171, a new sodium channel blocker being developed as an oral therapy for the treatment of peripheral neuropathic pain, is in Phase 1 clinical development. In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatm
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  The board of directors ... a quarterly cash dividend of $0.42 per share.  ... 2014 to stockholders of record at the close of ... AbbVie is a global, research-based biopharmaceutical company formed in ... to use its expertise, dedicated people and unique approach ...
(Date:9/19/2014)... Medical announces the formal launch of the largest ... on the market today at this weekend,s American Orthopaedic ... Chicago .  The Osteotomy Truss System is a comprehensive ... size options included in one versatile set. Previously available ... 18 implant sizes, which limited a surgeon,s ability to ...
(Date:9/19/2014)... 2014 The American Association for Homecare (AAHomecare) ... Manufacturing has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much ... quickly grown into a major global manufacturer of home ... AAHomecare to increase efforts on behalf of the HME ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... designs, develops, implements and supports electronic medical records ... significantly benefited from federal healthcare legislation during the ... to do so during the five years to ... and Clinical Health Act established Medicare and Medicaid ...
(Date:9/21/2014)... September 21, 2014 Best Cheap Hosting ... announced that Arvixe, Bluehost and GreenGeeks are the best ... find a good reseller hosting supplier. Actually, these companies ... speed and customer support. People can get the best ... says. , According to the manager, reseller hosting ...
(Date:9/21/2014)... Texas (PRWEB) September 21, 2014 ... (FDA) in 1996, GSK’s Flovent (fluticasone propionate) is ... It is used for the maintenance treatment of ... now available in two formulations, Diskus and HFA, ... 2004, respectively. Flovent’s active ingredient, fluticasone propionate, can ...
(Date:9/21/2014)... To accommodate the ever-growing customer base, ... more trendy items. Recently, the company has unveiled its ... new and elegant wedding gowns, Angeldress.co.uk wants to make ... in an easy way. Its high quality vintage wedding ... 12% off to 62% off. , Online shopping is ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... http://www.thegranuflolawsuit.com/ ) have been added over the past ... claims that allege serious cardiovascular injuries caused by ... A Case List updated on September 15th shows ... in the U.S. District Court, District of Massachusetts. ...
Breaking Medicine News(10 mins):Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4
... ... a vengeance, from epic winter storms to devastating earthquakes, our restless planet is asserting herself ... Supplies, Freeze Dried Food and Survival Kits on hand to weather the storms, warns SurvivalOutpost.com. ... (PRWEB) March 10, 2010 ...
... ... cats less aware of problem. , ... March 10, 2010 -- In the U.S., over 45% of dogs and 58% of cats are ... The third annual National Pet Obesity Awareness Day Study, conducted in October 2009, found that from ...
... ... ... ... ...
... ... “The 3 Day Thrush Cure” . People suffering from all types of thrush, including ... for this epidemic health problem. “The 3 Day Thrush Cure” fills a gap for ... , ...
... , ... ... ... ...
... a national workshop have been released to address deep-vein ... health problem estimated to affect nearly 1 million Americans ... group of representatives from federal health agencies and patient ... public health communities appear in the March 9, ...
Cached Medicine News:Health News:Recent Earthquakes Across the World Underscore the Importance of Emergency Preparedness Supplies and Survival Kits for Individuals, Families and Businesses 2Health News:Recent Earthquakes Across the World Underscore the Importance of Emergency Preparedness Supplies and Survival Kits for Individuals, Families and Businesses 3Health News:Pet Obesity Continues to Grow in U.S. 2Health News:Pet Obesity Continues to Grow in U.S. 3Health News:Pet Obesity Continues to Grow in U.S. 4Health News:For Latino Community, Health Reform Can't Wait 2Health News:For Latino Community, Health Reform Can't Wait 3Health News:For Latino Community, Health Reform Can't Wait 4Health News:For Latino Community, Health Reform Can't Wait 5Health News:For Latino Community, Health Reform Can't Wait 6Health News:For Latino Community, Health Reform Can't Wait 7Health News:For Latino Community, Health Reform Can't Wait 8Health News:Thrush Sufferers Seek Out Safe, Natural Remedies for Thrush, Driving a 237% Increase in Sales for "The 3 Day Thrush Cure" 2Health News:Thrush Sufferers Seek Out Safe, Natural Remedies for Thrush, Driving a 237% Increase in Sales for "The 3 Day Thrush Cure" 3Health News:IntraHealth International Opens Washington, D.C. Office 2Health News:IntraHealth International Opens Washington, D.C. Office 3Health News:IntraHealth International Opens Washington, D.C. Office 4Health News:IntraHealth International Opens Washington, D.C. Office 5Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 2Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 3
... The VersaFlex™ UES catheter is made ... allowing adjustment and choice of sensor distance., ... pH monitoring. , ,Alpine's VersaFlex catheters ... the market (4.7 French), and are the ...
... are efficient, economical, eliminate the risk ... comfort during the test period., ... been designed to use temperature correction ... calibration. The temperature correction factors for ...
FLEXILOG spare part....
Complete calibration kits are available for both pH and manometry systems....
Medicine Products: